Abbott Laboratories — Aurigene Pharmaceutical Services
Tracked across 1 events · 6 articles · First seen Aug 25, 2026 · Last active Aug 25, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Aurigene is the primary beneficiary, securing a long-term manufacturing and supply agreement that provides revenue visibility and scales up its drug-product business.
Aug 25, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Abbott Laboratories — Aurigene Pharmaceutical Services live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard